ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery

NCT01948440 | Completed Phase 2 DMC

• 1 other identifier: 2R44DA026232-02
• Study Type: interventional
• Target: 39
• Locations: 0 countries
• Sites: N/A

Brief Summary

Making referrals to medical and psychosocial services for substance abuse clients has proven difficult due to lack of access to services, inadequate counselor knowledge, and lack of motivation and skills among clients. Inflexxion is proposing the development of ASI-MV Solutions, which will educate clients about employment, legal, psychiatric, relapse prevention, medical, and family issues, as well as include resources and strategies for counselors. By linking learning modules to client results on the ASI-MV, an online interactive version of the ASI administered in treatment settings, we will be able to offer clients important tools to address key recovery issues and encourage counselors to make appropriate referrals to medical and psychosocial services.

Conditions

Substance Abuse Treatment for Adults

Keywords

Substance abuse, early recovery, relapse prevention

Outcome Measures

Primary Outcomes (4)

• improved outcomes, as measured by substance use, psychosocial, and psychological functioning

  Addiction Severity Index - Multimedia Version (ASI-MV)

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

• greater problem-services matching, as measured by the number and fit of referred/received services

  Treatment Services Checklist (Client Version) and Treatment Services Checklist (Counselor Version).

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

• greater treatment motivation

  Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES, Version 8D; Miller \& Tonigan, 1996)

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

• greater self-efficacy in managing psychosocial issues

  Drug Avoidance Self-Efficacy Scale

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

Secondary Outcomes (2)

• treatment compliance

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

• treatment alliance with counselors

  baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention

Study Arms (2)

ASI-MV Solutions

EXPERIMENTAL

The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions. The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.

Behavioral: ASI-MV Solutions

Treatment as Usual

NO INTERVENTION

The Control group participants will complete the ASI-MV and receive their normal course of treatment. The Control group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.

Interventions

ASI-MV Solutions BEHAVIORAL

The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions. The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.

ASI-MV Solutions

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

• None

Sponsors & Collaborators

• Inflexxion, Inc.: lead

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Emil Chiauzzi, PhD

  Inflexxion, Inc.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: NON RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Vice President of Product Strategy

Study Record Dates

• First Submitted: July 27, 2010
• First Posted: September 23, 2013
• Study Start: July 1, 2010
• Primary Completion: July 1, 2013
• Study Completion: July 1, 2013
• Last Updated: September 23, 2013

Record last verified: 2013-09